Comparative genomic hybridization study of arsenic-exposed and non-arsenic-exposed urinary transitional cell carcinoma

Toxicology and Applied Pharmacology
Ling-I HsuChien-Jen Chen

Abstract

To compare the differences in DNA aberrations between arsenic-exposed and non-arsenic-exposed transitional cell carcinoma (TCC), we analyzed 19 arsenic-exposed and 29 non-arsenic-exposed urinary TCCs from Chi-Mei Hospital using comparative genomic hybridization. DNA aberrations were detected in 42 TCCs including 19 arsenic-exposed and 23 non-arsenic-exposed TCCs. Arsenic-exposed TCCs had more changes than unexposed TCCs (mean+/-SD, 6.6+/-2.9 vs. 2.9+/-2.2). Arsenic exposure was significantly associated with the number of DNA aberrations after adjustment for tumor stage, tumor grade and cigarette smoking in multiple regression analysis. The most frequent DNA gains, which were strikingly different between arsenic-exposed and non-arsenic-exposed TCCs, included those at 1p, 4p, 4q and 8q. A much higher frequency of DNA losses in arsenic-exposed TCCs compared with non-arsenic-exposed TCCs was observed in 10q, 11p and 17p. Chromosomal loss in 17p13 was associated not only with arsenic exposure, but also with tumor stage and grade. The p53 immunohistochemistry staining showed that chromosome 17p13 loss was associated with either p53 no expression (25%) or p53 overexpression (75%). The findings suggest that long-term arsenic exposure m...Continue Reading

References

Aug 1, 1977·Acta Physiologica Scandinavica·L Persson
Dec 16, 1992·Mutation Research·A N JhaA T Natarajan
Jul 1, 1988·Science·T C LeeJ C Barrett
Jan 1, 1988·Cancer Genetics and Cytogenetics·R VanniE Usai
Jan 1, 1980·Environmental Mutagenesis·T G RossmanW Troll
Apr 21, 1995·International Journal of Cancer. Journal International Du Cancer·G SauterF M Waldman
Sep 1, 1995·Human Molecular Genetics·M P WilliamsonM A Knowles
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Q ZhaoM P Waalkes
Jun 3, 1999·Oncogene·N HornigoldM A Knowles
Mar 7, 2000·The American Journal of Pathology·W El-RifaiS Knuutila
Nov 21, 2002·Journal of the National Cancer Institute·Lee E MooreFrederic M Waldman
May 28, 2003·The Journal of Biological Chemistry·Lin LiuDavid L Keefe
May 29, 2003·Oncogene·Tahar O AboulkassimYves Fradet
Aug 16, 2003·Carcinogenesis·Lee E MooreFrederic M Waldman
Nov 25, 2003·Carcinogenesis·Giulia SciandrelloGiusi Barbata

❮ Previous
Next ❯

Citations

Nov 26, 2009·Occupational and Environmental Medicine·J VlaanderenR Vermeulen
Jul 19, 2011·Urologic Oncology·Merielen Garcia Nascimento e PontesJoão Lauro Viana de Camargo
Jul 31, 2013·Environmental and Molecular Mutagenesis·Lee E MooreKenneth P Cantor
Dec 17, 2011·Journal of Skin Cancer·Victor D MartinezWan L Lam
Sep 16, 2010·British Journal of Cancer·V D MartinezL Gil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.